This is odd. A blog on results of a “working paper” on Twitter behavior from a MBA student and professor at Harvard Business School.

Read the rest of this entry »

In case you managed to miss it, this round of NIH reviews will use a changed scoring system which we’ve previously discussed. It will also be associated with an unfamiliar summary statement. For those of us that review we will have to put away our venerable Stock Critique Templates. Fortunately, the Center for Scientific Review has provided a replacement along with a host of other informational documents on the new review system.

Read the rest of this entry »